Evaluation of a Deprescribing Guideline Mobile Application
The four evidence-based deprescribing guidelines and algorithms produced through the leadership of the Bruyère Research Institute and the Ontario Pharmacy Evidence Network, and the guideline developed through an NHMRC-ARC Dementia Research Fellowship have been built...
Acetylcholinesterase inhibitors and memantine deprescribing guideline
Using the evidence-based deprescribing guideline method established through the Bruyère Research Institute and the Ontario Pharmacy Evidence Network, Dr. Reeve developed an Australian/Canadian focused prescribing guideline for acetylcholinesterase inhibitors and...
Building Capacity for Deprescribing Guideline Development, Implementation, and Evaluation
This knowledge mobilization grant supported a variety of strategies designed to help health care providers and members of the public use deprescribing guidelines effectively. These included whiteboard training videos, mobile apps, webinars, a wide-reaching social...
A Multi-Method Approach to Exploring Prescribing Cascades
Prescribing cascades occur a drug is used to treat the side effect of another drug. How and why prescribing cascades start and continue, their impact on patients, and how they can be prevented or reversed are all unknown. This research project will help identify...
Deprescribing Initiatives using Community Engagement (DICE)
The Deprescribing Initiatives Using Community Engagement (DICE) project explores how public and health care professional community engagement strategies can be used to implement deprescribing into the routine care of patients in a community within the Champlain Local...
Fostering collective impact across Newfoundland and Labrador
The province of Newfoundland and Labrador has some of the highest use of potentially harmful medications in seniors compared to the rest of Canada. In collaboration with the Department of Health and Community Services and their Appropriateness of Care Initiative, we...